Orit Bar‐Am

Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer’s, Parkinson’s, and other neurodegenerative diseases

Hailin Zheng, Lev Weiner, Orit Bar‐Am et al. · Bioorganic & Medicinal Chemistry · 2004 · 276 citations

Neurodegenerative Diseases, Alzheimer's Disease, Biochemistry +9

Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases: <i>in vitro</i> studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition

Hailin Zheng, Shunit Gal, Lev Weiner et al. · Journal of Neurochemistry · 2005 · 213 citations

Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members

Orly Weinreb, Orit Bar‐Am, Tamar Amit et al. · The FASEB Journal · 2004 · 186 citations

Apoptosis, Cell Death, Social Sciences +20

Regulation of Bcl‐2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine

Orit Bar‐Am, Orly Weinreb, Tamar Amit et al. · The FASEB Journal · 2005 · 164 citations

App Processing, Apoptosis, Neurotransmitter +20

Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease¹

Yael Avramovich‐Tirosh, Tamar Amit, Orit Bar‐Am et al. · Journal of Neurochemistry · 2006 · 131 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Drug Candidates +14